Understanding the New Treatment Era of Alternative Therapies for Patients With Hemophilia A

Get the latest clinical data and expert perspectives on a new treatment era for hemophilia A including emerging data and patient preferences on alternative therapies.

Share

Program Content

Activities

Hemophilia A Toolkit
Moderate to Severe Hemophilia A: Patient/Caregiver Preference Assessment Tool Kit and Checklist for Clinicians
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: July 02, 2019

Expires: June 30, 2020

Activities

Hemophilia A Therapy
Understanding the New Treatment Era of Alternative Therapies for Patients With Hemophilia A
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: June 28, 2019

Expires: June 27, 2020

Faculty

cover img faculity

Guy Young, MD

Director, Hemostasis and Thrombosis Center
Director, Clinical Coagulation Laboratory
Cancer and Blood Disorders Institute
Children's Hospital Los Angeles
Professor of Pediatrics
Division of Hematology/Oncology
Department of Pediatrics
University of Southern California Keck School of Medicine
Los Angeles, California

cover img faculity

Michael Callaghan, MD

Associate Professor
Department of Hematology
Wayne State University
Hematologist
Division of Hematology/Oncology
Childrens Hospital of Michigan
Detroit, Michigan

cover img faculity

Miguel A. Escobar, MD

Professor of Medicine and Pediatrics
Division of Hematology
McGovern Medical School
Director
Gulf States Hemophilia and Thrombophilia Center
Houston, Texas

cover img faculity

Cindy A. Leissinger, MD

Director
Louisiana Center for Bleeding and Clotting Disorders
New Orleans, Louisiana

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Genentech TEXT Only